Form 8-K - Current report:
SEC Accession No. 0000950170-22-014732
Filing Date
2022-08-04
Accepted
2022-08-04 16:03:39
Documents
14
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20220804.htm   iXBRL 8-K 50218
2 EX-99.1 cytk-ex99_1.htm EX-99.1 343243
3 GRAPHIC img114956760_0.jpg GRAPHIC 5599
  Complete submission text file 0000950170-22-014732.txt   539181

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytk-20220804_lab.xml EX-101.LAB 13466
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytk-20220804_pre.xml EX-101.PRE 9900
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytk-20220804.xsd EX-101.SCH 2469
8 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20220804_htm.xml XML 4764
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 221136418
SIC: 2834 Pharmaceutical Preparations